Clinical Researcher—May 2019 (Volume 33, Issue 5) EXECUTIVE DIRECTOR’S MESSAGE Jim Kremidas Two hundred and fifty years ago, when the British empire ruled the Atlantic Ocean, Scottish physician James Lind […]
As patient advocate groups, the U.S. Food and Drug Administration, and many others clamor for better minority patient representation in clinical trials, there’s one important tool we might be overlooking, […]
“Most people's experience with healthcare is similar and it's frustrating,” says Meredith Karney, speaking from direct experience. As a 36-year-old with a history of Hodgkin’s lymphoma since 2002, she’s had […]
A new U.S. Food and Drug Administration (FDA) guidance is designed to help practitioners conduct clinical trials that often feature relatively delicate young patient populations struggling with attention deficit hyperactivity […]
Clinical trial professionals are muddling through when it comes to grappling with technology day-to-day on the job, with about one-third of those responding to an in-depth survey saying the systems […]